Morgan Stanley Pro Mis Neurosciences Inc. Transaction History

Morgan Stanley

  • $1.27 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$3.7 - $8.14 $2,590 - $5,698
-700 Reduced 27.91%
1,808 $7,000
Q1 2023

May 15, 2023
SELL
$4.06 - $5.71 $1,217 - $1,713
-300 Reduced 10.68%
2,508 $11,000
Q4 2022

Feb 14, 2023
SELL
$4.33 - $6.29 $13,518 - $19,637
-3,122 Reduced 52.65%
2,808 $12,000
Q3 2022

Nov 14, 2022
BUY
$4.99 - $9.25 $29,590 - $54,852
5,930 New
5,930 $36,000

Others Institutions Holding PMN

# of Institutions
17
Shares Held
3.26M
Call Options Held
0
Put Options Held
0
View Full List

About ProMIS Neurosciences Inc.

PMN Quotes by TradingView
  • Ticker PMN
  • Exchange OTC
  • Description
  • ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...
More about PMN
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email